Free Trial

Vaccine Timeline Uncertainty

BRAZIL

There appeared to be mounting confusion yesterday surrounding vaccinations as an important rollout meeting was delayed by one week by Brazil's Health Minister Pazuello. This announcement came following the release of Brazilian data which showed that Sinovac's vaccine efficacy was less than 60%. Given the most recent communique that the efficacy is only just above the 50% threshold for regulatory approval, uncertainty remains heightened and developments will be monitored closely.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.